 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 2002, 22(22):10039-10045
Enhanced Locomotor, Reinforcing, and Neurochemical Effects
of Cocaine in Serotonin 5-Hydroxytryptamine 2C
Receptor Mutant Mice
Beatriz A.
Rocha1, 2, *,
Evan H.
Goulding3, *,
Laura
E.
O'Dell4,
Andy N.
Mead1,
Nicole G.
Coufal3,
Loren H.
Parsons4, and
Laurence H.
Tecott3
1 National Institute on Drug Abuse/Intramural Research
Program, Baltimore, Maryland 21224, 2 University of
Maryland/Maryland Psychiatric Research Center, Baltimore, Maryland
21247, 3 Department of Psychiatry and Center for
Neurobiology and Psychiatry, University of California, San Francisco,
San Francisco, California 94143-0984, and 4 Department of
Neuropharmacology, The Scripps Research Institute, La Jolla, California
92037
Brain serotonin [5-hydroxytryptamine (5-HT)] systems
substantially influence the effects of cocaine; however,
the contributions of individual 5-HT receptor subtypes to the
regulation of cocaine responses are unclear. A line of mutant mice
devoid of 5-HT2C receptors was used to examine the contribution of this
receptor subtype to the serotonergic modulation of cocaine responses.
Mutants display enhanced exploration of a novel environment and
increased sensitivity to the locomotor stimulant effects of cocaine. In an operant intravenous self-administration model under a progressive ratio schedule of reinforcement, mutants display elevated levels of
lever pressing for cocaine injections, indicating that the drug is more
reinforcing in these mice. Moreover, mutants exhibit enhanced
cocaine-induced elevations of dopamine (DA) levels in the nucleus
accumbens, a brain region implicated in the stimulant and rewarding
properties of cocaine. In contrast, phenotypic differences in dorsal
striatal DA levels were not produced by cocaine treatment. These
findings strongly implicate 5-HT2C receptors in the serotonergic suppression of DA-mediated behavioral responses to cocaine and as a
potential therapeutic target for cocaine abuse.
Key words:
cocaine; serotonin; serotonin 2c receptor; behavior; reinforcement; mice
*
B.A.R. and E.H.G. contributed equally to this work.
Copyright © 2002 Society for Neuroscience 0270-6474/02/222210039-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
W. J. Thomsen, A. J. Grottick, F. Menzaghi, H. Reyes-Saldana, S. Espitia, D. Yuskin, K. Whelan, M. Martin, M. Morgan, W. Chen, et al.
Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
577 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Carnell, J. Illi, S. W. Hong, and S. L. McIntire
The G-Protein-Coupled Serotonin Receptor SER-1 Regulates Egg Laying and Male Mating Behaviors in Caenorhabditis elegans
J. Neurosci.,
November 16, 2005;
25(46):
10671 - 10681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. O'Dell and L. H. Parsons
Serotonin1B Receptors in the Ventral Tegmental Area Modulate Cocaine-Induced Increases in Nucleus Accumbens Dopamine Levels
J. Pharmacol. Exp. Ther.,
November 1, 2004;
311(2):
711 - 719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. De Deurwaerdere, S. Navailles, K. A Berg, W. P. Clarke, and U. Spampinato
Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens
J. Neurosci.,
March 31, 2004;
24(13):
3235 - 3241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Compan, M. Zhou, R. Grailhe, R. A. Gazzara, R. Martin, J. Gingrich, A. Dumuis, D. Brunner, J. Bockaert, and R. Hen
Attenuated Response to Stress and Novelty and Hypersensitivity to Seizures in 5-HT4 Receptor Knock-Out Mice
J. Neurosci.,
January 14, 2004;
24(2):
412 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Carrasco, Y. Zhang, K. J. Damjanoska, D. N. D'Souza, F. Garcia, G. Battaglia, N. A. Muma, and L. D. Van de Kar
A Region-Specific Increase in G{alpha}q And G{alpha}11 Proteins in Brains of Rats during Cocaine Withdrawal
J. Pharmacol. Exp. Ther.,
December 1, 2003;
307(3):
1012 - 1019.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|